Moderna Inc. (MRNA) News

Moderna Inc. (MRNA): $107.89

3.43 (+3.28%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

C

Add MRNA to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#177 of 359

in industry

Filter MRNA News Items

MRNA News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

MRNA News Highlights

  • MRNA's 30 day story count now stands at 23.
  • Over the past 18 days, the trend for MRNA's stories per day has been choppy and unclear. It has oscillated between 1 and 4.
  • AMP, LI and GENE are the most mentioned tickers in articles about MRNA.

Latest MRNA News From Around the Web

Below are the latest news stories about MODERNA INC that investors may wish to consider to help them evaluate MRNA as an investment opportunity.

Tech Stalls As Rising Bond Yields Spook Investors

It's been an inauspicious start to the 2024 trading year, with all three major indexes in the red midday.

TalkMarkets.com | January 2, 2024

The Biggest Losers in S&P 500 This Year: Dollar General, Moderna, and More

The five worst performers in the market benchmark so far this year could be set for brighter futures.

Yahoo | December 28, 2023

Walgreens, Nike, Moderna: Bargain hunting stocks

The most recent bull market run has been widely described as "weird," with several household stocks underperforming during the bull run on S&P 500 (^GSPC) components. Yahoo Finance Reporter Madison Mills showcases three of these companies — Moderna (MRNA), Walgreens (WBA), and Nike (NKE) — where investors may find the most value for a bargain price on the stocks. For more expert insight and the latest market action, click here to watch this full episode of Yahoo Finance Live.

Yahoo | December 28, 2023

S&P 500 Is Nearing a Record High. This Could Derail It in 2024.

Microsoft and OpenAI are sued by the New York Times for copyright infringement, Amazon plans to launch adverts on Prime Video next month, and other news to start your day.

Yahoo | December 28, 2023

The Winners and Losers: 2023 Stock Market Performance Review

The 2023 stock market saw steep declines followed by rapid upswings, but we're ending the year on a high note (even if some stocks aren't).

Jeremy Flint on InvestorPlace | December 27, 2023

Moderna and Pfizer Stock Tumbled in 2023. Wall Street Sees a Rebound.

Covid-19-vaccine makers Moderna and Pfizer saw shares drop in 2023, but analysts expect double-digit-percentage gains next year.

Yahoo | December 27, 2023

Why Is RayzeBio (RYZB) Stock Up 100% Today?

RYZB stock has doubled today after Bristol Myers Squibb shelled out $4.1 billion to buy RayzeBio.

Dana Blankenhorn on InvestorPlace | December 26, 2023

Should You Buy This Year's Worst-Performing S&P 500 Stocks for 2024?

Some of this year's underperformers could have brighter futures.

Yahoo | December 25, 2023

20 Best Countries for Doctors to Immigrate to

In this article, we will list and explore the 20 best countries for doctors to immigrate to. You can skip our detailed analysis and go directly to our list of 5 Best Countries for Doctors to Immigrate to. For many medical professionals, the United States has historically been an attractive destination due to its renowned healthcare […]

Yahoo | December 23, 2023

What to Know About the New Fast-Spreading Covid-19 Strain

The alert about the new variant, called JN.1, comes as hospitalizations of patients with Covid-19 are climbing in the U.S., amid a seasonal increase in respiratory virus hospitalizations.

Yahoo | December 21, 2023


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!